SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-19-059683
Filing Date
2019-03-01
Accepted
2019-03-01 10:27:26
Documents
7
Effectiveness Date
2019-03-01

Document Format Files

Seq Description Document Type Size
1 POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ON FORM S-3 d682569dposasr.htm POSASR 508007
2 EXHIBIT 23.2 d682569dex232.htm EX-23.2 1819
3 EX-23.3 d682569dex233.htm EX-23.3 1652
4 GRAPHIC g682569g04l02.jpg GRAPHIC 117575
5 GRAPHIC g682569g51n01.jpg GRAPHIC 41598
6 GRAPHIC g682569g72b50.jpg GRAPHIC 102821
7 GRAPHIC g682569g79k14.jpg GRAPHIC 42841
  Complete submission text file 0001193125-19-059683.txt   932724
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-224702 | Film No.: 19647174
SIC: 2834 Pharmaceutical Preparations